Clinical trials
Phase 2 trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
240 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 7 |
| 2008 | 13 |
| 2009 | 10 |
| 2010 | 10 |
| 2011 | 12 |
| 2012 | 14 |
| 2013 | 15 |
| 2014 | 10 |
| 2015 | 12 |
| 2016 | 12 |
| 2017 | 13 |
| 2018 | 8 |
| 2019 | 14 |
| 2020 | 10 |
| 2021 | 10 |
| 2022 | 11 |
| 2023 | 13 |
| 2024 | 12 |
| 2025 | 8 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 148 |
| Terminated | 43 |
| Recruiting | 18 |
| Active, not recruiting | 16 |
| Unknown status | 13 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 29 |
| Novartis Pharmaceuticals | 28 |
| Pfizer | 16 |
| Hoffmann-La Roche | 10 |
| Bristol-Myers Squibb | 9 |
| MedImmune LLC | 7 |
| Bayer | 6 |
| Genentech, Inc. | 6 |
| GlaxoSmithKline | 6 |
| Sanofi | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 28 |
| Arthritis, Rheumatoid | 26 |
| Asthma | 11 |
| Breast Neoplasms | 10 |
| COVID-19 | 9 |
| Dengue | 7 |
| Lupus Nephritis | 7 |
| Autoimmune Diseases | 6 |
| Coronary Artery Disease | 5 |
| Non-alcoholic Fatty Liver Disease | 5 |
Trials
Showing 76 to 100 of 240. Each trial links to its page on Pharma Observatory.
140 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.